Overview

Leflunomide in Systemic Lupus Erythematosus

Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
A pilot study to evaluate the efficacy and safety of leflunomide in SLE patients with active disease who are refractory to cyclophosphamide
Phase:
Phase 2
Details
Lead Sponsor:
Sanofi
Treatments:
Leflunomide